CRISPR/Cas9 therapeutics: progress and prospects.
Li T, Yang Y, Qi H, Cui W, Zhang L, Fu X, He X, Liu M, Li PF, Yu T.
Li T, et al. Among authors: cui w.
Signal Transduct Target Ther. 2023 Jan 16;8(1):36. doi: 10.1038/s41392-023-01309-7.
Signal Transduct Target Ther. 2023.
PMID: 36646687
Free PMC article.
Review.